# WillScot Holdings Corp: financial statements, quarterly

WSC · Nasdaq · CIK 1647088 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/wsc.md) · [Financials](/companies/wsc/financials.md) · [Filings](/companies/wsc/filings.md) · [Insiders](/companies/wsc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/wsc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [605](/filings/0001647088-24-000159.md) | [612 d](/filings/0001647088-26-000011.md) | [587](/filings/0001647088-25-000029.md) | [605](/filings/0001647088-25-000046.md) | [601](/filings/0001647088-25-000066.md) | [603 d](/filings/0001647088-26-000011.md) | [560](/filings/0001647088-26-000031.md) | [589](/filings/0001647088-26-000056.md) | [567](/filings/0001647088-25-000066.md) | [566 d](/filings/0001647088-26-000011.md) | [549](/filings/0001647088-26-000031.md) | [612](/filings/0001647088-26-000056.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | [340](/filings/0001647088-24-000159.md) | [343 d](/filings/0001647088-26-000011.md) | [317](/filings/0001647088-25-000029.md) | [327](/filings/0001647088-25-000046.md) | [321](/filings/0001647088-25-000066.md) | [336 d](/filings/0001647088-26-000011.md) | [300](/filings/0001647088-26-000031.md) | [296](/filings/0001647088-26-000056.md) | [282](/filings/0001647088-25-000066.md) | [286 d](/filings/0001647088-26-000011.md) | [286](/filings/0001647088-26-000031.md) | [306](/filings/0001647088-26-000056.md) |
| Selling, general and administrative | $m | [152](/filings/0001647088-24-000159.md) | [146 d](/filings/0001647088-26-000011.md) | [168](/filings/0001647088-25-000029.md) | [181](/filings/0001647088-25-000046.md) | [153](/filings/0001647088-25-000066.md) | [128 d](/filings/0001647088-26-000011.md) | [157](/filings/0001647088-26-000031.md) | [145](/filings/0001647088-26-000056.md) | [138](/filings/0001647088-25-000066.md) | [142 d](/filings/0001647088-26-000011.md) | [154](/filings/0001647088-26-000031.md) | [160](/filings/0001647088-26-000056.md) |
| Operating income | $m | [178](/filings/0001647088-24-000159.md) | [177 d](/filings/0001647088-26-000011.md) | [130](/filings/0001647088-25-000029.md) | [(5.2)](/filings/0001647088-25-000046.md) | [(35.2)](/filings/0001647088-25-000066.md) | [174 d](/filings/0001647088-26-000011.md) | [119](/filings/0001647088-26-000031.md) | [127](/filings/0001647088-26-000056.md) | [119](/filings/0001647088-25-000066.md) | [(184) d](/filings/0001647088-26-000011.md) | [96.7](/filings/0001647088-26-000031.md) | [117](/filings/0001647088-26-000056.md) |
| Interest expense | $m | [53.8](/filings/0001647088-23-000087.md) | [59.1 d](/filings/0001647088-24-000030.md) | [56.6](/filings/0001647088-24-000087.md) | [55.5](/filings/0001647088-24-000143.md) | [55.8](/filings/0001647088-24-000159.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [32.8](/filings/0001647088-23-000087.md) | [31.7 d](/filings/0001647088-26-000011.md) | [17.1](/filings/0001647088-24-000087.md) | [(13.9)](/filings/0001647088-24-000143.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [91.5](/filings/0001647088-24-000159.md) | [86.3 d](/filings/0001647088-26-000011.md) | [56.2](/filings/0001647088-25-000066.md) | [(46.9)](/filings/0001647088-25-000066.md) | [(70.5)](/filings/0001647088-25-000066.md) | [89.2 d](/filings/0001647088-26-000011.md) | [43.1](/filings/0001647088-26-000056.md) | [47.9](/filings/0001647088-26-000056.md) | [43.3](/filings/0001647088-25-000066.md) | [(187) d](/filings/0001647088-26-000011.md) | [28.1](/filings/0001647088-26-000056.md) | [47.0](/filings/0001647088-26-000056.md) |
| Diluted EPS | $ per share | [0.46](/filings/0001647088-24-000159.md) | not reported | [0.29](/filings/0001647088-25-000029.md) | [(0.25)](/filings/0001647088-25-000046.md) | [(0.37)](/filings/0001647088-25-000066.md) | not reported | [0.23](/filings/0001647088-26-000031.md) | [0.26](/filings/0001647088-26-000056.md) | [0.24](/filings/0001647088-25-000066.md) | not reported | [0.15](/filings/0001647088-26-000031.md) | [0.26](/filings/0001647088-26-000056.md) |
| Basic EPS | $ per share | [0.47](/filings/0001647088-24-000159.md) | not reported | [0.30](/filings/0001647088-25-000029.md) | [(0.25)](/filings/0001647088-25-000046.md) | [(0.37)](/filings/0001647088-25-000066.md) | not reported | [0.23](/filings/0001647088-26-000031.md) | [0.26](/filings/0001647088-26-000056.md) | [0.24](/filings/0001647088-25-000066.md) | not reported | [0.16](/filings/0001647088-26-000031.md) | [0.26](/filings/0001647088-26-000056.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: not reported
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [5.8](/filings/0001647088-23-000087.md) | [11.0](/filings/0001647088-25-000009.md) | [13.1](/filings/0001647088-24-000087.md) | [5.9](/filings/0001647088-24-000143.md) | [11.0](/filings/0001647088-24-000159.md) | [9.0](/filings/0001647088-26-000011.md) | [10.7](/filings/0001647088-25-000029.md) | [12.9](/filings/0001647088-25-000046.md) | [14.8](/filings/0001647088-25-000066.md) | [14.6](/filings/0001647088-26-000056.md) | [15.5](/filings/0001647088-26-000031.md) | [18.2](/filings/0001647088-26-000056.md) |
| Current assets | $m | [569](/filings/0001647088-23-000087.md) | [569](/filings/0001647088-25-000009.md) | [575](/filings/0001647088-24-000087.md) | [576](/filings/0001647088-24-000143.md) | [578](/filings/0001647088-24-000159.md) | [558](/filings/0001647088-26-000011.md) | [518](/filings/0001647088-25-000029.md) | [530](/filings/0001647088-25-000046.md) | [520](/filings/0001647088-25-000066.md) | [525](/filings/0001647088-26-000056.md) | [530](/filings/0001647088-26-000031.md) | [557](/filings/0001647088-26-000056.md) |
| Total assets | $m | [6,075](/filings/0001647088-23-000087.md) | [6,138](/filings/0001647088-25-000009.md) | [6,180](/filings/0001647088-24-000087.md) | [6,049](/filings/0001647088-24-000143.md) | [6,037](/filings/0001647088-24-000159.md) | [6,035](/filings/0001647088-26-000011.md) | [5,962](/filings/0001647088-25-000029.md) | [6,105](/filings/0001647088-25-000046.md) | [6,105](/filings/0001647088-25-000066.md) | [5,816](/filings/0001647088-26-000056.md) | [5,811](/filings/0001647088-26-000031.md) | [5,866](/filings/0001647088-26-000056.md) |
| Current liabilities | $m | [547](/filings/0001647088-23-000087.md) | [562](/filings/0001647088-25-000009.md) | [596](/filings/0001647088-24-000087.md) | [632](/filings/0001647088-24-000143.md) | [639](/filings/0001647088-24-000159.md) | [585](/filings/0001647088-26-000011.md) | [621](/filings/0001647088-25-000029.md) | [656](/filings/0001647088-25-000046.md) | [660](/filings/0001647088-25-000066.md) | [611](/filings/0001647088-26-000056.md) | [670](/filings/0001647088-26-000031.md) | [687](/filings/0001647088-26-000056.md) |
| Total liabilities | $m | [4,763](/filings/0001647088-23-000087.md) | [4,877](/filings/0001647088-25-000009.md) | [4,860](/filings/0001647088-24-000087.md) | [4,847](/filings/0001647088-24-000143.md) | [4,983](/filings/0001647088-24-000159.md) | [5,016](/filings/0001647088-26-000011.md) | [4,950](/filings/0001647088-25-000029.md) | [5,070](/filings/0001647088-25-000046.md) | [5,045](/filings/0001647088-25-000066.md) | [4,960](/filings/0001647088-26-000056.md) | [4,940](/filings/0001647088-26-000031.md) | [4,955](/filings/0001647088-26-000056.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [1,313](/filings/0001647088-24-000159.md) | [1,261](/filings/0001647088-26-000011.md) | [1,320](/filings/0001647088-25-000066.md) | [1,201](/filings/0001647088-25-000066.md) | [1,054](/filings/0001647088-25-000066.md) | [1,019](/filings/0001647088-26-000056.md) | [1,011](/filings/0001647088-26-000056.md) | [1,035](/filings/0001647088-26-000056.md) | [1,060](/filings/0001647088-25-000066.md) | [856](/filings/0001647088-26-000056.md) | [871](/filings/0001647088-26-000056.md) | [911](/filings/0001647088-26-000056.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [191 d](/filings/0001647088-24-000159.md) | [219 d](/filings/0001647088-26-000011.md) | [209](/filings/0001647088-25-000029.md) | [176 d](/filings/0001647088-25-000046.md) | [(1.6) d](/filings/0001647088-25-000066.md) | [179 d](/filings/0001647088-26-000011.md) | [207](/filings/0001647088-26-000031.md) | [205 d](/filings/0001647088-26-000056.md) | [191 d](/filings/0001647088-25-000066.md) | [159 d](/filings/0001647088-26-000011.md) | [191](/filings/0001647088-26-000031.md) | [162 d](/filings/0001647088-26-000056.md) |
| Capital expenditure | $m | [5.6 d](/filings/0001647088-24-000159.md) | [5.5 d](/filings/0001647088-26-000011.md) | [6.6](/filings/0001647088-25-000029.md) | [6.2 d](/filings/0001647088-25-000046.md) | [3.3 d](/filings/0001647088-25-000066.md) | [2.3 d](/filings/0001647088-26-000011.md) | [4.6](/filings/0001647088-26-000031.md) | [6.3 d](/filings/0001647088-26-000056.md) | [4.2 d](/filings/0001647088-25-000066.md) | [9.2 d](/filings/0001647088-26-000011.md) | [3.6](/filings/0001647088-26-000031.md) | [4.7 d](/filings/0001647088-26-000056.md) |
| Dividends paid | $m | not reported | not reported | [0.0](/filings/0001647088-25-000029.md) | [0.0 d](/filings/0001647088-25-000046.md) | [0.0 d](/filings/0001647088-25-000066.md) | [0.0 d](/filings/0001647088-26-000011.md) | [12.9](/filings/0001647088-26-000031.md) | [12.8 d](/filings/0001647088-26-000056.md) | [12.7 d](/filings/0001647088-25-000066.md) | [12.8 d](/filings/0001647088-26-000011.md) | [12.7](/filings/0001647088-26-000031.md) | [12.7 d](/filings/0001647088-26-000056.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | Q4 FY2022 (2022-12-31) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [214](/filings/0001647088-23-000014.md) | [210](/filings/0001647088-24-000087.md) | [204](/filings/0001647088-24-000143.md) | [199](/filings/0001647088-24-000159.md) | [193](/filings/0001647088-25-000029.md) | [190](/filings/0001647088-25-000046.md) | [188](/filings/0001647088-25-000066.md) | [185](/filings/0001647088-26-000031.md) | [183](/filings/0001647088-26-000056.md) | [183](/filings/0001647088-25-000066.md) | [181](/filings/0001647088-26-000031.md) | [182](/filings/0001647088-26-000056.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 181,190,958 at 2026-07-30, from the cover of the [10-Q filed 2026-08-06](/filings/0001647088-26-000056.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.